Literature DB >> 28340140

Lipidomic profiling of endometrial fluid in women with ovarian endometriosis†.

Francisco Domínguez1,2, Marcos Ferrando3, Patricia Díaz-Gimeno1,2, Fernando Quintana3, Gemma Fernández3, Inés Castells3, Carlos Simón2,4.   

Abstract

The proteomic content of the endometrial fluid (EF) from patients with endometriosis has been investigated, but the lipidomic profile has not been analyzed yet in detail.This study is a comparative untargeted lipidomic analysis of human EF obtained from 35 patients (12 endometriosis and 23 controls). Global differential lipidomic profile was analyzed in both groups by ultrahigh performance liquid chromatography coupled to mass spectrometry. A total of 123 out of the 457 metabolites identified in the EF were found to be significantly differentially expressed between ovarian endometriosis (OE) versus controls. Univariate statistical analysis showed reduced levels of saturated diacylglycerols and saturated triacylglycerols in endometriosis patients. A predictive model was generated using the 123 differentially expressed metabolites. Using this model, we were able to correctly classify 86% of the samples. This study identified the lipidomic profile in the EF associated with OE, suggesting that EF analysis could be considered as a minimally invasive approach for the diagnosis of endometriosis. In conclusion, the lipidomic profile of the EF is different between samples from patients with OE and controls.
© The Authors 2017. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved. For permissions, please journals.permissions@oup.com.

Entities:  

Keywords:  endometrial fluid; endometriosis; lipidomic profile

Mesh:

Substances:

Year:  2017        PMID: 28340140     DOI: 10.1093/biolre/iox014

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  9 in total

Review 1.  Challenges in uncovering non-invasive biomarkers of endometriosis.

Authors:  Quanah J Hudson; Alexandra Perricos; Rene Wenzl; Iveta Yotova
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-04

2.  Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.

Authors:  Oana A Zeleznik; Clary B Clish; Peter Kraft; Julian Avila-Pacheco; A Heather Eliassen; Shelley S Tworoger
Journal:  J Natl Cancer Inst       Date:  2020-06-01       Impact factor: 13.506

3.  The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles.

Authors:  Roberto Matorras; Ibon Martinez-Arranz; Enara Arretxe; Marta Iruarrizaga-Lejarreta; Blanca Corral; Jone Ibañez-Perez; Antonia Exposito; Begoña Prieto; Felix Elortza; Cristina Alonso
Journal:  J Assist Reprod Genet       Date:  2019-12-21       Impact factor: 3.412

4.  [Research progress on biomarkers for endometriosis based on lipidomics].

Authors:  Cuicui Lin; Zhengyun Chen; Chunyan Wang; Yongmei Xi
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-25

Review 5.  Metabolomics for Diagnosis and Prognosis of Uterine Diseases? A Systematic Review.

Authors:  Janina Tokarz; Jerzy Adamski; Tea Lanišnik Rižner
Journal:  J Pers Med       Date:  2020-12-21

Review 6.  Metabolomics in endometriosis: challenges and perspectives for future studies.

Authors:  Camila N Ortiz; Annelyn Torres-Reverón; Caroline B Appleyard
Journal:  Reprod Fertil       Date:  2021-05-06

Review 7.  Clinical use of artificial intelligence in endometriosis: a scoping review.

Authors:  Brintha Sivajohan; Mohamed Elgendi; Carlo Menon; Catherine Allaire; Paul Yong; Mohamed A Bedaiwy
Journal:  NPJ Digit Med       Date:  2022-08-04

8.  Dysregulated sphingolipid metabolism and autophagy in granulosa cells of women with endometriosis.

Authors:  Bongkoch Turathum; Er-Meng Gao; Khwanthana Grataitong; Yu-Bing Liu; Ling Wang; Xue Dai; Ri-Cheng Chian
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-03       Impact factor: 6.055

Review 9.  The Endometriotic Tumor Microenvironment in Ovarian Cancer.

Authors:  Jillian R Hufgard Wendel; Xiyin Wang; Shannon M Hawkins
Journal:  Cancers (Basel)       Date:  2018-08-07       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.